The PriorNilsson Sverige Aktiv fund climbed 0.50 percent in November, outperforming its benchmark index, which edged up by 0.02 percent. Since the start of the year, the fund has returned 6.8 percent, lagging behind the index, which has gained 10.3 percent. These figures are detailed in the fund's monthly report.

 At the outset, the fund managers note that healthcare stocks performed strongly during the month.

The managers highlight that this may be attributed to previously weak performance as well as a less negative news flow regarding pharmaceutical companies from the United States.

Positive contributions came from holdings in Volvo, Astra Zeneca, Asker, and banking stocks. In Volvo's case, reduced negative impact from tariffs and potentially favorable implementation of emission regulations in the United States were cited.

Astra Zeneca, Asker, Sobi, and Novo Nordisk were among the top performers. Bank stocks continued to benefit from rising long-term interest rates and have been some of the strongest performers in the large-cap segment this year.

Among the weaker holdings for the month were Ericsson, Hexagon, Alfa Laval, and Skanska. Ericsson retreated after a strong October, while Skanska's weak third-quarter report weighed on its share price.

During the month, the fund increased its holdings in Novo Nordisk, Sobi, and Trelleborg.

At the same time, exposure was reduced in Orion, Verisure, Skanska, and Handelsbanken.

The largest holdings in the fund's portfolio at the end of the month were Ericsson, Alfa Laval, and Atlas Copco, with portfolio weights of 9.7, 8.8, and 8.7 percent, respectively.

The main sectors were industry, finance, and technology, with weights of 39.70, 24.66, and 14.58 percent, respectively.

PriorNilsson Sverige Aktiv, % November, 2025
Fund MoM, percentage change 0.50
Index MoM, percentage change 0.02
Fund YTD, percentage change 6.8
Index YTD, percentage change 10.3